GT BIOPHARMA INC (GTBP) Stock Income Statement
NASDAQ:GTBP - Nasdaq - US36254L3087 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 13.77M | 14.36M | 13.58M | 21.26M | 57.52M | |||
| Research and Development | 5.22M | 5.80M | 6.47M | 8.81M | 9.59M | |||
| Selling, General, and Administrative Expenses | 8.54M | 8.57M | 7.11M | 12.45M | 47.92M | |||
| Operating Income | -13.77M | -14.36M | -13.58M | -21.26M | -57.52M | |||
| Interest Income/Expense | 529.00K | 402.00K | 615.00K | 254.00K | -709.00K | |||
| Other Income/Expense | 891.00K | 800.00K | 4.82M | 119.00K | 211.00K | |||
| Non Recurring Items | N/A | N/A | 547.00K | N/A | 0.00 | |||
| Income Before Taxes | -12.35M | -13.16M | -7.60M | -20.88M | -58.01M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -12.35M | -13.16M | -7.60M | -20.88M | -58.01M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -7.47 | -6.94 | -5.64 | -19.66 | -61.81 | |||
| Non GAAP EPS | N/A | N/A | -5.79 | -20.10 | -80.10 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD